Topics

Companies Related to "Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome" [Most Relevant Company Matches] RSS

06:42 EST 24th January 2020 | BioPortfolio

Here are the most relevant search results for "Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome" found in our extensive corporate database of over 50,000 company records.

Showing "Linking Endotypes Outcomes Pediatric Acute Respiratory Distress Syndrome" Companies 1–25 of 1,500+

Extremely Relevant

Discovery Laboratories

Discovery Laboratories, Inc. is a specialty pharmaceutical company leveraging its platform technology in humanized lung surfactants to develop novel respiratory therapies and pulmonary drug delivery products. Surfactants are produced naturally in the lungs and are essential to the lungs' ability to absorb oxygen.Our humanized surfactant technology is being developed initially for critical care pa...


Advanced Discovries for Health

We are a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs in the areas of infectious disease, inflammation and oncology. Using our internal discovery capabilities and our network of pharmaceutical and academic partners, we have assembled a promising pipeline of clinical and preclinical product candidates for the treatment of respiratory tract inf...

Vapotherm, Inc.

Vapotherm, Inc. is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The Company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 1.7 million patients have been treated with Vapotherm Hi-VNI Techn...


Relevant

Respiratory Therapeutics Group

RTG is a global manufacturer of Respiratory Devices, with an extensive brand portfolio of respiratory disposable devices, products and service solutions designed by Respiratory Therapists for a diverse range of therapies. RTG Products are distributed in Acute, Sub Acute, Skilled Nursing, Home and Hospice Settings, through our increasing network of d...

Novaliq GmbH

"Novaliq GmbH is a medical technology / biopharmaceutical company with the aim to develop and market life-saving drug delivery systems for the treatment of severe lung diseases, such as for example acute respiratory distress syndrome (ARDS). The so-called semifluorinated alkanes (SFA) used for this purpose can equally be developed and used as carrier fluid or aerosol for the transport of pharmaceu...

Evolutec Group plc

Evolutec discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. Evolutec has progressed its lead therapeutic molecule, rEV131, a novel histamine binding protein, from discovery to completion of initial Phase II clinical trials in allergic conjunctivitis, rhinitis and ocular inflammation. Positive preclinical data has also been generated in asthma ...

Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and Defense Medicine(TM). The company has developed a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte(TM)) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that inc...

ALung Technologies, Inc.

ALung Technologies, Inc. is commercializing artificial lung devices for the treatment of acute and chronic respiratory disorders. The company's Hemolung System, designed to replace or supplement the use of ventilators for patients with acute respiratory failure, is scheduled to begin clinical trials in the fall of 2009. Learn more about ALung and Hemolung at www.alung.com.

Barlow Respiratory Hospital

Barlow Respiratory Hospital is the only not-for-profit, long-term, acute care respiratory hospital in Southern California. We specialize in caring for critically ill, complex patients. We offer nationally recognized programs such as ventilator weaning, pulmonary rehabilitation, wound care, and palliative care.

Research Down Syndrome

Research Down Syndrome (RDS) is a non-profit foundation which funds research at leading institutions directed towards identifying safe and effective biomedical therapies to treat the intellectual difficulties associated with Down syndrome. RDS' mission is to educate and inspire society to fund and support Down syndrome cognitive research to enhance and expand life opportunities, helping people wit...

Pulmatrix, Inc.

Pulmatrix, Inc., is a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases. Pulmatrix’s lead proprietary therapies, called inhaled cationic airway lining modulators (iCALM™), are a novel approach to prevent and treat acute exacerbations an...

Advanced Life Sciences Holding

We are a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs in the areas of infectious disease, inflammation and oncology. Using our internal discovery capabilities and our network of pharmaceutical and academic partners, we have assembled a promising pipeline of clinical and preclinical product candidates for the treatment of respiratory tract inf...

Sjogren's Syndrome Foundation

Founded in 1983, the Sjogren's Syndrome Foundation (SSF) provides patients with practical information and coping strategies that minimize the effects of Sjogren's syndrome. In addition, the Foundation is the clearinghouse for medical information and is the recognized national advocate for Sjogren's syndrome. The Foundation's mission is to educate patients and their families about Sjogren's syndrom...

Anthera Pharmaceuticals, Inc.

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. Anthera has one Phase 3 clinical program, A-002, and two Phase 2 clinical programs, A-623 and A-001. A-002 and A-001 inhibit a novel enzyme target known as secretory phospholipase A2 (sPLA...

The International Rett Syndrome Foundation

While there are over 3,800 known cases of Rett Syndrome in the United States which predominantly strikes only girls, the disorder is genetically linked to more widespread neurological disorders such as autism and schizophrenia. Rett symptoms begin to manifest between the first six to eighteen months of life and in most cases will eventually incapacitate the afflicted children so that they can...

Pulmatrix

Pulmatrix is discovering and developing a new class of therapies --inhaled cationic airway lining modulators (iCALM) –to prevent and treat respiratory infections and acute exacerbations of chronic respiratory diseases. iCALM therapies have broad potential to treat and prevent a wide range of respiratory diseases, including respiratory infections such ...

Vapotherm, Inc

Vapotherm, Inc. is dedicated to the development of unique and advanced technologies for respiratory airway therapies...especially for the treatment of chronic lung and acute breathing disorders.The company focuses on innovative products which allow high flow, non-invasive delivery of respiratory gases...particularly where conventional technologies fail.

US Post Acute Care LLC

US Post Acute Care is a Management Services Organization providing value-added service to clinical practice groups specializing in the care of patients in the post-acute setting. An organization with a national footprint, US Post Acute Care provides a full array of management services including billing, recruiting, training, compliance, analytics, and practice development. US Post Acute Care stru...

Voorhees Pediatric Facility

Voorhees Pediatric Facility is a nationally recognized pediatric specialty care center that offers 119 in-patient beds and the largest freestanding pediatric ventilator program in the country. Our mission and vision are to advance the full life potential of medically fragile children and to set the national standard for excellence in pediatric long-term sp...

Voorhees Pediatric Facility and Weisman Children’s Rehabilitation Hospital

Voorhees Pediatric Facility is a nationally recognized pediatric specialty care center that offers 121 in-patient beds and the largest freestanding pediatric ventilator program in the country. Our mission and vision is to advance the full life potential of medically fragile children and to set the national standard for excellence in pediatric long-term spe...

Global Down Syndrome Foundation

The Global Down Syndrome Foundation is a public non-profit 501(c)(3) dedicated to significantly improving the lives of people with Down syndrome through research, medical care, education, and advocacy. Formally established in 2009, the Foundation’s primary focus is to support the Linda Crnic Institute for Down Syndrome, the first academic home in the ...

Promise Healthcare, Inc.

Based in Boca Raton, Florida, Promise Healthcare is one of the largest long-term acute care (LTAC) hospital organizations in the country. With more than 2,000 staff members and 13 hospitals nationwide, Promise Hospitals utilize an interdisciplinary approach to healing and wellness. Promise’s distinctive LTAC environment provides acute medical care and ...

Promise Healthcare

Headquartered in Boca Raton, Florida, Promise Healthcare, Inc. (www.promisehealthcare.com) is one of the largest long-term acute care (LTAC) hospital organizations in the country. With more than 5,000 staff members and 19 health care facilities nationwide, Promise hospitals utilize an interdisciplinary approach to healing and wellness. Promise’s distinctive ...

Uniphy Health

Uniphy Health provides clinical communication and collaboration solutions that are used in acute and post-acute care settings to help medical teams work more effectively and improve outcomes. Additionally, the company serves the patient community and caregivers at home and in nursing facilities, and helps healthcare systems address operational and financia...

Therabron Therapeutics, Inc.

Therabron Therapeutics, Inc. is a clinical-stage biotechnology company, founded in 2007 and located in Rockville, MD. Therabron is focused on the advancement of respiratory therapeutics with disease-modifying potential. The company’s product candidates aim to restore the natural immune balance in the lungs of respiratory patients through the administr...


More From BioPortfolio on "Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome"

Quick Search

Corporate Database Quicklinks